$0.6449
-0.005-0.77%
Last update: Oct 23, 7:02 PM
Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote, News & History
CLDIAMEX
Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results and raising its FY26 EPS guidance. Other gaining stocks...
You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Calidi Biotherapeutics has a consensus price target of $3200.00.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $0.6584 last updated October 23, 2026 at 7:02 PM EDT.
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered...
